Shattuck Labs

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Shattuck Labs and other ETFs, options, and stocks.

About STTK

Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms.

CEO

Taylor H. Schreiber

CEOTaylor H. Schreiber

Employees

Employees85

Headquarters

Austin, Texas

HeadquartersAustin, Texas

Founded

2016

Founded2016

Employees

Employees85

STTK Key Statistics

Market cap

114.86M

Market cap114.86M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

93.75K

Average volume93.75K

High today

$2.85

High today$2.85

Low today

$2.69

Low today$2.69

Open price

$2.70

Open price$2.70

Volume

469.28K

Volume469.28K

52 Week high

$21.42

52 Week high$21.42

52 Week low

$2.55

52 Week low$2.55

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

STTK Earnings

-$0.65

-$0.37

-$0.10

$0.18

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 9, Pre-Market

ActualExpected Nov 9, Pre-Market

Shattuck Labs

Why Robinhood?

Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. Show more

STTK Key Statistics

Analyst ratings

100%

Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms.